Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy

Despite LLT, FH patients still develop cardiovascular events and especially subsequent events. Classical risk factors such as smoking and hypertension are driving factors for this risk, indicating the high priority of optimizing risk factor reduction in addition to maximum LLT.